Kelun-Biotech’s Tagitanlimab Approved for NPC First-Line Treatment
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company“) announced that the Company received marketing authorization in China from National Medical Products Administration (NMPA) for the programmed cell death ligand...